Beyond GLP-1: the next wave of weight-loss medication innovation

“There is a real sense now of a rapid expansion in the area of novel medications in the area of obesity,” says Hannah Beba, pharmacist and clinical lead for obesity at West Yorkshire Integrated Care System. Amira Guirguis, pharmacy professor and chair of the Science and Research Committee of the Royal Pharmaceutical Society, agrees: “I […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.375713
Primary Topic: Pharmacology and Obesity Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Beyond GLP-1: the next wave of weight-loss medication innovation

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Pharmacology and Obesity Treatment

article

Beyond GLP-1: the next wave of weight-loss medication innovation

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Openalex Percentile: Top 69%

Pharmacology and Obesity Treatment

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Beyond GLP-1: the next wave of weight-loss medication innovation · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS